sur Eckert & Ziegler Strahlen- Und Medizintechnik AG (isin : DE0005659700)
Eckert & Ziegler: Spin-off of Pentixapharm AG Registered
Berlin, 2 October 2024. Eckert & Ziegler SE announced that the spin-off resolution approved at the Annual General Meeting on 26 June 2024 has been entered in the commercial register of the Charlottenburg District Court. With this, the spin-off of Pentixapharm AG became legally effective. Accordingly, all shares in Pentixapharm AG held by Eckert & Ziegler have been transferred to Pentixapharm Holding AG.
In return, Eckert & Ziegler shareholders will receive Pentixapharm Holding AG shares at a 1:1 ratio. Their entitlement will be based on the number of Eckert & Ziegler shares held after the close of trading today. All shares created through the spin-off are expected to be admitted to Frankfurt Stock Exchange’s Prime Standard segment on 2 October 2024.
Initial trading of Pentixapharm Holding AG shares is scheduled for 3 October 2024. On the same day, the listing of Eckert & Ziegler SE shares ‘ex spin-off’ is planned. The deposit-side posting of Pentixapharm Holding shares to securities accounts of Eckert & Ziegler shareholders is expected on 7 October 2024.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Eckert & Ziegler Strahlen- Und Medizintechnik AG